DAPTOMYCIN
ESPID Education. Chidiac C. 05/06/10; 4842
Christian Chidiac
Christian Chidiac

This content is available to ESPID members only


Click here for more information or if you are considering becoming an ESPID member.

Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
After viewing this presentation the participant will be able to:

- Review the efficacy and spectrum of action of daptomycin in experimental models of MRSA and GISA
- Compare current clinical data of daptomycin in adults in comparison with other antibiotics
- Review the pharmacokinetics properties of daptomycin in children
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies